![](/img/cover-not-exists.png)
Personalised Thienopyridine Therapy: The Cost Effectiveness of Testing for CYP2C19 Variants to Guide Treatment in Patients with Acute Coronary Syndromes
Laura Panattoni, Braden Te Ao, Paul Brown, Patrick GladdingVolume:
20
Year:
2011
Language:
english
DOI:
10.1016/j.hlc.2011.03.035
File:
PDF, 2.39 MB
english, 2011